Convergence: Confusion lingers over interchangeability and switching of biosimilars
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsGlobalPreclinical studyQuality Assurance and ControlRegulatory Intelligence/Policy